Back to discover
Disease

Paraneoplastic Syndromes, Nervous System

Emerging research
1
Publications
2021
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Research2021-05-18Neurology(R) neuroimmunology & neuroinflammation

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Neurology(R) neuroimmunology & neuroinflammation · 2021 · 459 cites
Recent publications

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.

Neurology(R) neuroimmunology & neuroinflammation · 2021 · 459 cites
Leading journals1
  • Neurology(R) neuroimmunology & neuroinflammation1
Leading researchers8
  • Antoine JG1
  • Dalmau J1
  • Desestret V1
  • Dubey D1
  • Giometto B1
  • Graus F1
  • Honnorat J1
  • Irani SR1
Affiliations (unnormalised)1
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. (Intern Med 1996 Dec;35(12):925-9)

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.